NeuroScientific Biopharmaceuticals Limited (ASX:NSB)

ASX:NSB Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	4.49	4.95	4.91	7.22	14.16	3.29
Cash & Short-Term Investments	4.49	4.95	4.91	7.22	14.16	3.29
Cash Growth	34.67%	0.86%	-31.93%	-49.05%	330.88%	-28.70%
Receivables	0.08	0.05	0.04	0.12	0.05	0.02
Prepaid Expenses	0.09	0.04	0.05	0.06	0.22	-
Total Current Assets	4.66	5.04	5.01	7.4	14.43	3.31
Property, Plant & Equipment	0	0.01	0.01	0.02	0.03	0.01
Other Intangible Assets	0.34	0.39	0.27	0.32	0.37	0.42
Total Assets	5.01	5.44	5.29	7.74	14.83	3.74
Accounts Payable	0.03	0.08	0.59	2.17	0.18	0.06
Accrued Expenses	0	0	0.01	0.05	0.05	0.03
Total Current Liabilities	0.03	0.09	0.6	2.22	0.22	0.09
Total Liabilities	0.03	0.09	0.6	2.22	0.22	0.09
Common Stock	25.52	25.52	25.27	25.27	25.27	11.72
Retained Earnings	-21.85	-22.04	-22.99	-22.6	-12.18	-9.15
Comprehensive Income & Other	1.31	1.87	2.41	2.84	1.5	1.08
Shareholders' Equity	4.98	5.35	4.69	5.52	14.6	3.65
Total Liabilities & Equity	5.01	5.44	5.29	7.74	14.83	3.74
Net Cash (Debt)	4.49	4.95	4.91	7.22	14.16	3.29
Net Cash Growth	34.67%	0.86%	-31.93%	-49.05%	330.88%	-28.70%
Net Cash Per Share	0.03	0.03	0.03	0.05	0.10	0.04
Filing Date Shares Outstanding	144.6	144.6	143.47	143.47	143.47	78.38
Total Common Shares Outstanding	144.6	144.6	143.47	143.47	143.47	78.38
Working Capital	4.64	4.96	4.41	5.18	14.2	3.22
Book Value Per Share	0.03	0.04	0.03	0.04	0.10	0.05
Tangible Book Value	4.64	4.96	4.42	5.2	14.23	3.23
Tangible Book Value Per Share	0.03	0.03	0.03	0.04	0.10	0.04

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.